Cargando…

Selenoneine Ameliorates Hepatocellular Injury and Hepatic Steatosis in a Mouse Model of NAFLD

Selenoneine is a novel organic selenium compound markedly found in the blood, muscles, and other tissues of fish. This study aimed to determine whether selenoneine attenuates hepatocellular injury and hepatic steatosis in a mouse model of non-alcoholic fatty liver disease (NAFLD). Mice lacking farne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyata, Masaaki, Matsushita, Koki, Shindo, Ryunosuke, Shimokawa, Yutaro, Sugiura, Yoshimasa, Yamashita, Michiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353312/ https://www.ncbi.nlm.nih.gov/pubmed/32604760 http://dx.doi.org/10.3390/nu12061898

Ejemplares similares

Nutritional Supplementation and Enhanced Antioxidant Function by Dietary Intake of Selenoneine and Other Selenium Compounds in Red Seabream Pagrus major
por: Shimokawa, Yutaro, et al.
Publicado: (2023)

Dietary Supplementation of Selenoneine-Containing Tuna Dark Muscle Extract Effectively Reduces Pathology of Experimental Colorectal Cancers in Mice
por: Masuda, Junko, et al.
Publicado: (2018)

Selenoneine, a Novel Selenium-Containing Compound, Mediates Detoxification Mechanisms against Methylmercury Accumulation and Toxicity in Zebrafish Embryo
por: Yamashita, Michiaki, et al.
Publicado: (2013)

Identification and Determination of Selenoneine, 2-Selenyl-N(α), N(α), N(α)-Trimethyl-l-Histidine, as the Major Organic Selenium in Blood Cells in a Fish-Eating Population on Remote Japanese Islands
por: Yamashita, Michiaki, et al.
Publicado: (2013)

Hepatic Steatosis, Carbohydrate Intake, and Food Quotient in Patients with NAFLD
por: Gonzalez, Concepcion, et al.
Publicado: (2013)

Parenteral Nutrition Associated Hepatic Steatosis and NAFLD Intersect at AMPK
por: Guthrie, Gregory
Publicado: (2022)

Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice
por: Matsui, Masahiro, et al.
Publicado: (2021)

Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis
por: Serrano-Maciá, Marina, et al.
Publicado: (2021)

Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis
por: Bernhardt, Philipp, et al.
Publicado: (2018)

Ergothioneine, Ovothiol A, and Selenoneine—Histidine-Derived, Biologically Significant, Trace Global Alkaloids
por: Cordell, Geoffrey A., et al.
Publicado: (2022)

Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model
por: Niu, Shu, et al.
Publicado: (2022)

Follistatin Alleviates Hepatic Steatosis in NAFLD via the mTOR Dependent Pathway
por: Tong, Junlu, et al.
Publicado: (2022)

Betaine in ameliorating alcohol-induced hepatic steatosis
por: Rehman, Aisha, et al.
Publicado: (2021)

Genetic and Metabolomic Dissection of the Ergothioneine and Selenoneine Biosynthetic Pathway in the Fission Yeast, S. pombe, and Construction of an Overproduction System
por: Pluskal, Tomáš, et al.
Publicado: (2014)

A Computational Model of Hepatic Energy Metabolism: Understanding Zonated Damage and Steatosis in NAFLD
por: Ashworth, William B., et al.
Publicado: (2016)

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Nier, Anika, et al.
Publicado: (2020)

MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis
por: Segura-Azuara, Nancy de los Ángeles, et al.
Publicado: (2022)

Iron metabolism mediates the relationship between Vitamin C and hepatic steatosis and fibrosis in NAFLD
por: Hu, Zhengyu, et al.
Publicado: (2022)

Acupuncture improved hepatic steatosis in HFD-induced NAFLD rats by regulating intestinal microbiota
por: Wang, Haiying, et al.
Publicado: (2023)

TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice
por: Wandrer, Franziska, et al.
Publicado: (2020)

Quercitrin Ameliorates Hyperlipidemia and Hepatic Steatosis in Ovariectomized Mice
por: Hur, Haeng Jeon, et al.
Publicado: (2020)

Correction: Genetic and Metabolomic Dissection of the Ergothioneine and Selenoneine Biosynthetic Pathway in the Fission Yeast, S. pombe, and Construction of an Overproduction System
Publicado: (2014)

Fucoidan and Fucoxanthin Attenuate Hepatic Steatosis and Inflammation of NAFLD through Modulation of Leptin/Adiponectin Axis
por: Shih, Ping-Hsiao, et al.
Publicado: (2021)

IGFBP-2 as a biomarker in NAFLD improves hepatic steatosis: an integrated bioinformatics and experimental study
por: Chen, Xu, et al.
Publicado: (2021)

Rhamnetin ameliorates non-alcoholic steatosis and hepatocellular carcinoma in vitro
por: Shatta, Mahmoud A., et al.
Publicado: (2022)

Hepatocellular Carcinoma in a Patient With Hepatic Steatosis
por: Romano, John, et al.
Publicado: (2020)

Comparison between magnetic resonance and ultrasound-derived indicators of hepatic steatosis in a pooled NAFLD cohort
por: Beyer, Cayden, et al.
Publicado: (2021)

The relationship between Lipocalin-2 level and hepatic steatosis in obese patients with NAFLD after bariatric surgery
por: Chen, Jiaqi, et al.
Publicado: (2022)

HADHA alleviates hepatic steatosis and oxidative stress in NAFLD via inactivation of the MKK3/MAPK pathway
por: Ding, Jiexia, et al.
Publicado: (2022)

Vitamin D improves hepatic steatosis in NAFLD via regulation of fatty acid uptake and β-oxidation
por: Du, Tingwan, et al.
Publicado: (2023)

Risk Stratification of Advanced Fibrosis in HIV Patients With Hepatic Steatosis Using the NAFLD Fibrosis and BARD Scores
por: YENDEWA, George A., et al.
Publicado: (2023)

Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma
por: Jeong, Seogsong, et al.
Publicado: (2023)

Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress
por: Palladini, Giuseppina, et al.
Publicado: (2019)

Losartan Prevents Hepatic Steatosis and Macrophage Polarization by Inhibiting HIF-1α in a Murine Model of NAFLD
por: Wang, Cheng-Hui, et al.
Publicado: (2021)

AgNPs Aggravated Hepatic Steatosis, Inflammation, Oxidative Stress, and Epigenetic Changes in Mice With NAFLD Induced by HFD
por: Wen, Ling, et al.
Publicado: (2022)

Phyllanthus emblica aqueous extract retards hepatic steatosis and fibrosis in NAFLD mice in association with the reshaping of intestinal microecology
por: Luo, Xiaomin, et al.
Publicado: (2022)

Correction: The relationship between Lipocalin-2 level and hepatic steatosis in obese patients with NAFLD after bariatric surgery
por: Chen, Jiaqi, et al.
Publicado: (2023)

Silencing of FABP1 ameliorates hepatic steatosis, inflammation, and oxidative stress in mice with nonalcoholic fatty liver disease
por: Mukai, Takako, et al.
Publicado: (2017)

LPSF/GQ-02 Inhibits the Development of Hepatic Steatosis and Inflammation in a Mouse Model of Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Soares e Silva, Amanda Karolina, et al.
Publicado: (2015)

Eriocitrin ameliorates diet-induced hepatic steatosis with activation of mitochondrial biogenesis
por: Hiramitsu, Masanori, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1843a0kr3f8v2j3via2cqmd1mt